1. Chen, Yi-Yu, Ge, Jing-Yu, Zhu, Si-Yuan, Shao, Zhi-Ming, Yu, Ke-Da. 2022. Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis. In Nature communications, 13, 791. doi:10.1038/s41467-022-28452-z. https://pubmed.ncbi.nlm.nih.gov/35145111/
2. Hached, Khaled, Goguet, Perrine, Charrasse, Sophie, Lorca, Thierry, Castro, Anna. 2019. ENSA and ARPP19 differentially control cell cycle progression and development. In The Journal of cell biology, 218, 541-558. doi:10.1083/jcb.201708105. https://pubmed.ncbi.nlm.nih.gov/30626720/
3. Gouttia, Odjo G, Zhao, Jing, Li, Yanqiu, Oakley, Gregory G, Peng, Aimin. 2022. The MASTL-ENSA-PP2A/B55 axis modulates cisplatin resistance in oral squamous cell carcinoma. In Frontiers in cell and developmental biology, 10, 904719. doi:10.3389/fcell.2022.904719. https://pubmed.ncbi.nlm.nih.gov/36247015/
4. Yi, Zhen, Ouyang, Jiamin, Sun, Wenmin, Xiao, Xueshan, Zhang, Qingjiong. 2020. Comparative exome sequencing reveals novel candidate genes for retinitis pigmentosa. In EBioMedicine, 56, 102792. doi:10.1016/j.ebiom.2020.102792. https://pubmed.ncbi.nlm.nih.gov/32454406/